Literature DB >> 6284968

Deletions within the transformation-specific RNA sequences of acute leukemia virus MC29 give rise to partially transformation-defective mutants.

K Bister, G M Ramsay, M J Hayman.   

Abstract

The viral RNAs of three nonconditional mutants of avian myelocytomatosis virus MC29 were analyzed. These mutants, which were originally isolated from the quail producer line Q10 and were designated 10A, 10C, and 10H, have lost most of the ability to transform hematopoietic cells in vitro and to induce tumors in vivo, but they still transform cultured fibroblasts with the same efficiency as wild-type (wt) MC29. Electrophoretic analyses showed that the mutant genomic RNAs were smaller than the 5.7-kilobase genome of wt MC29; the genomes of mutants 10A, 10C, and 10H were about 5.5, 5.3, and 5.1 kilobases long, respectively. Analyses of the transformation-specific sequences of these mutant RNAs by a combination of T(1) oligonucleotide fingerprinting and hybridization with cDNA from the transformation-specific sequences myc of wt MC29 or competition hybridization including wt MC29 RNA revealed that deletions of myc-specific sequences had occurred. The deletions in all three mutants overlapped, since they all had lost one particular myc-specific oligonucleotide. In agreement with the size of the genomic RNAs, mutants 10C and 10H had lost two additional myc oligonucleotides, and mutant 10A contained a modified myc oligonucleotide. The locations of the deletions were deduced from comparisons with previously established oligonucleotide maps of several members of the MC29 subgroup of acute leukemia viruses and by hybridization of wt and mutant RNAs to molecularly cloned subgenomic fragments of wt MC29 proviral DNA, representing the 5' and 3' domains of the myc sequence. We found that the deleted sequences represented overlapping internal segments of the myc sequence and that the borders of myc with the partial complements of the virion genes gag and env appeared to be conserved in mutant and wt MC29 RNAs. The correlation between the altered transforming potential for hematopoietic cells and the partial deletion of myc in the mutant RNAs provided direct genetic evidence for the involvement of myc in oncogenesis. However, the unaffected efficiency of these mutants in fibroblast transformation suggested that the deleted sequences are not essential for the fibroblast-transforming potential of the onc gene of MC29.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284968      PMCID: PMC256813     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Agarose slab-gel electrophoresis equipment.

Authors:  B Sugden; B De Troy; R J Roberts; J Sambrook
Journal:  Anal Biochem       Date:  1975-09       Impact factor: 3.365

2.  Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis.

Authors:  K Bister; M J Hayman; P K Vogt
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

3.  RNA tumor viruses of pheasants: characterization of avian leukosis subgroups F and G.

Authors:  D J Fujita; Y C Chen; R R Friis; P K Vogt
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

4.  Strain MC29 avian leukosis virus. Myelocytoma, endothelioma, and renal growths: pathomorphological and ultrastructural aspects.

Authors:  Z Mladenov; U Heine; D Beard; J W Beard
Journal:  J Natl Cancer Inst       Date:  1967-03       Impact factor: 13.506

5.  Calcium-dependent bacteriophage DNA infection.

Authors:  M Mandel; A Higa
Journal:  J Mol Biol       Date:  1970-10-14       Impact factor: 5.469

6.  Molecular cloning of avian myelocytomatosis virus (MC29) transforming sequences.

Authors:  J A Lautenberger; R A Schulz; C F Garon; P N Tsichlis; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Proposal for naming host cell-derived inserts in retrovirus genomes.

Authors:  J M Coffin; H E Varmus; J M Bishop; M Essex; W D Hardy; G S Martin; N E Rosenberg; E M Scolnick; R A Weinberg; P K Vogt
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

8.  Component of strain MC29 avian leukosis virus with the property of defectiveness.

Authors:  R Ishizaki; A J Langlois; J Chabot; J W Beard
Journal:  J Virol       Date:  1971-12       Impact factor: 5.103

9.  Structural relationship between a normal chicken DNA locus and the transforming gene of the avian acute leukemia virus MC29.

Authors:  T Robins; K Bister; C Garon; T Papas; P Duesberg
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

10.  Isolation and biochemical characterization of partially transformation-defective mutants of avian myelocytomatosis virus strain MC29: localization of the mutation to the myc domain of the 110,000-dalton gag-myc polyprotein.

Authors:  G M Ramsay; M J Hayman
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more
  27 in total

Review 1.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

2.  Molecular cloning of proviral DNA and structural analysis of the transduced myc oncogene of avian oncovirus CMII.

Authors:  N Walther; R Lurz; T Patschinsky; H W Jansen; K Bister
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Nucleotide sequence of HBI, a novel recombinant MC29 derivative with altered pathogenic properties.

Authors:  D R Smith; B Vennstrom; M J Hayman; P J Enrietto
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

4.  Isolation of an MH2 retrovirus mutant temperature sensitive for macrophage but not fibroblast transformation.

Authors:  S Palmieri
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

5.  Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins.

Authors:  M L Heaney; J Pierce; J T Parsons
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas.

Authors:  P Münzel; D Marx; H Köchel; A Schauer; K W Bock
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  FH3, a v-myc avian retrovirus with limited transforming ability.

Authors:  C Chen; B J Biegalke; R N Eisenman; M L Linial
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Recovery of myc-specific sequences by a partially transformation-defective mutant of avian myelocytomatosis virus, MC29, correlates with the restoration of transforming activity.

Authors:  G M Ramsay; P J Enrietto; T Graf; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Acute leukemia viruses E26 and avian myeloblastosis virus have related transformation-specific RNA sequences but different genetic structures, gene products, and oncogenic properties.

Authors:  K Bister; M Nunn; C Moscovici; B Perbal; M Baluda; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  Isolation and biochemical characterization of partially transformation-defective mutants of avian myelocytomatosis virus strain MC29: localization of the mutation to the myc domain of the 110,000-dalton gag-myc polyprotein.

Authors:  G M Ramsay; M J Hayman
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.